Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/30/2009EP2138172A1 Anti-viral agent
12/30/2009EP2138171A1 Veterinarian compositions containing terpinen-4-ol for the treatment and prevention of mastitis
12/30/2009EP2138170A2 Prevention and Treatment of Oxidative Stress Disorders by compounds which elevate intracellular levels of glutathione or Phase II Detoxification Enzymes
12/30/2009EP2138169A2 Transdermal delivery system of hormones without penetration enhancers
12/30/2009EP2138167A1 Pharmaceutical composition comprising N-[2-(Diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene) methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
12/30/2009EP2138164A1 Liquid pharmaceutical formulations of docetaxel
12/30/2009EP2138163A2 Suppository formulations comprising tenofovir or tenofovir disoproxil
12/30/2009EP2138162A2 Gel comprising tenofovir or tenofovir disoproxil
12/30/2009EP2138055A1 Formula food to be beneficial for visuognosis persistence and use thereof
12/30/2009EP2138054A1 Plant extract for the prevention or treatment of snoring and/or sleep apnoea
12/30/2009EP2137536A1 Methods and compositions for inducing apoptosis by stimulating er stress
12/30/2009EP2137513A2 Mix for identification test in the process of quality control of the medicine "glycine tablets for sublingual applying 0,1g" methods of its preparation and identity evaluation in the process of quality control of the aforementioned medicine
12/30/2009EP2137203A1 Ethynylated heterodinucleoside phosphate analogs, method for the production thereof, and use thereof
12/30/2009EP2137202A1 Process for the synthesis of ib-meca
12/30/2009EP2137201A2 Process for preparing capecitabine
12/30/2009EP2137196A1 Tricyclic nitrogen containing compounds as antibacterial agents
12/30/2009EP2137193A2 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
12/30/2009EP2137192A1 Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
12/30/2009EP2137186A1 Heterocyclic compounds and their uses
12/30/2009EP2137184A1 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
12/30/2009EP2137177A2 Aurora kinase modulators and method of use
12/30/2009EP2137175A1 Novel phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome
12/30/2009EP2137172A1 Phenothiazin derivatives for antiviral treatments
12/30/2009EP2137170A1 Desferrithiocin polyether analogues
12/30/2009EP2137167A1 Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives
12/30/2009EP2137166A1 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/30/2009EP2137165A1 Inhibitors of protein kinases
12/30/2009EP2137164A1 Inhibitors of protein kinases
12/30/2009EP2137163A1 Inhibitors of protein kinases
12/30/2009EP2137156A1 Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for parkinson's disease prevention or treatment
12/30/2009EP2137155A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases
12/30/2009EP2137152A1 Novel benzamide derivatives and process for the preparation thereof
12/30/2009EP2137150A1 Piperidinones useful in the treatment of inflammation
12/30/2009EP2137147A1 Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer
12/30/2009EP2137146A1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
12/30/2009EP2137143A1 Pleuromutilin derivatives for the treatment of diseases mediated by microbes
12/30/2009EP2137141A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents
12/30/2009EP2137132A2 Isoprenoid compounds, their isolation and use
12/30/2009EP2136846A1 Therapeutic targets and molecules
12/30/2009EP2136821A2 Oral zinc medicants useful for safely lowering free copper absorption and free copper levels
12/30/2009EP2136818A1 Use of oligotide for the treatment of renal diseases
12/30/2009EP2136816A2 Oleyl phosphocholine
12/30/2009EP2136814A1 Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture
12/30/2009EP2136813A2 Compositions and method for treating pediatric hypogonadism
12/30/2009EP2136812A1 Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria
12/30/2009EP2136811A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/30/2009EP2136810A1 Novel 1,8-naphthyridine compounds
12/30/2009EP2136809A2 Raf kinase inhibitors containing a zinc binding moiety
12/30/2009EP2136808A2 Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors
12/30/2009EP2136807A1 Pyrrolo (3, 2, 1-ij) quinoline-4-one derivatives for treating tuberculosis
12/30/2009EP2136806A1 Method and means for preventing and inhibiting type iii secretion in infections caused by gram-negative bacteria
12/30/2009EP2136804A1 Indolizine acetic acid derivatives as crth2 antagonists
12/30/2009EP2136803A1 Triazole derivatives which are smo antagonists
12/30/2009EP2136802A2 Use of fungicides for treating fish mycoses
12/30/2009EP2136801A1 Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
12/30/2009EP2136800A1 Modulation of bacterial quorum sensing with synthetic ligands
12/30/2009EP2136797A2 Intranasally administering curcumin in a bolus of helium gas to treat alzheimer's disease
12/30/2009EP2136793A2 Tablet formulations containing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom
12/30/2009EP2136792A1 Hot-melt micropellets
12/30/2009EP2136789A2 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
12/30/2009EP2136788A1 Cancer cell targeting using nanoparticles
12/30/2009EP2136785A1 Process for dosing self-emulsifying drug delivery systems
12/30/2009EP2136784A1 Bio-absorbable oil suspension
12/30/2009EP2136782A1 Ophthalmic oil-in-water emulsions containing prostaglandins
12/30/2009EP2136780A1 Use of ranolazine for the treatment of cardiovascular diseases
12/30/2009EP2136639A1 Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
12/30/2009EP2136638A1 Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same
12/30/2009EP2136637A1 Inhibitors of cholesterol ester transfer protein
12/30/2009EP2136635A1 Chemical compounds
12/30/2009EP2136634A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/30/2009EP2136633A1 Oncolytic vaccinia virus cancer therapy
12/30/2009EP2136632A1 Chemical compounds
12/30/2009EP2136631A1 Methods for treating neoplasia with combination of chemotherapeutic agents and radiation
12/30/2009EP2136626A1 Mannich base n-oxide drugs
12/30/2009EP2136624A1 Allylqxy and alkyloxy benzoic acid delivery agents
12/30/2009EP2057148B1 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents
12/30/2009EP2049525B1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
12/30/2009EP2004653B1 3-substituted n-(aryl- or heteroaryl)-pyrazo[1,5-a]pyrimidines as kinase inhibitors
12/30/2009EP2004625B1 C-met protein kinase inhibitors for the treatment of proliferative disorders
12/30/2009EP1989218B1 17-phosphorous steroid derivatives useful as progesterone receptor modulators
12/30/2009EP1928427B1 Novel dosage formulation
12/30/2009EP1919483B1 Combined preparation of a thiazide diuretic and a loop diuretic
12/30/2009EP1805202B1 Conjugates with anti-inflammatory activity
12/30/2009EP1763343B1 Calcium trifluoroacetate for preparing antiangiogenetic medicaments
12/30/2009EP1742945B1 Substituted phenylamino-pyrimidines
12/30/2009EP1732902B1 Nucleoside derivatives and therapeutic use thereof
12/30/2009EP1727532B1 Chemically stable compositions of 4-hydroxy tamoxifen
12/30/2009EP1711481B1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
12/30/2009EP1682542B1 Novel crystalline anhydride with anticholinergic effect
12/30/2009EP1678161B1 Thioether-substituted benzamides as inhibitors of factor xa
12/30/2009EP1664027B1 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use
12/30/2009EP1620395B1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
12/30/2009EP1613587B1 Organic compounds
12/30/2009EP1608632B1 Quinazolines useful as modulators of ion channels
12/30/2009EP1608352B1 Polyamine compounds for treating chemokine receptor mediated diseases
12/30/2009EP1562949B1 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
12/30/2009EP1558577B1 Substituted 4-phenyl-piperidin-amides as tachykinin antagonists and serotonin reptake inhibitors
12/30/2009EP1532149B1 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments
12/30/2009EP1501812B1 Pna monomer and precursor
12/30/2009EP1501498B1 Pharmaceutical composition comprising a lipase inhibitor and glucomannan
1 ... 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 ... 7860